Trial NCT01712399

View at ClinicalTrials.gov 
Org. Study IDs: CD-IA-CAM-3001-1109
Secondary IDs: Earth Explorer X

Last trial update was posted on 2017-06-01

MeSH Interventions

Mavrilimumab

MeSH Conditions

Arthritis Arthritis, Rheumatoid

Other Conditions

Rheumatoid Arthritis

Stopping Reasons

The study was terminated after approximately 3 years due to future clinical development plans, including ethical considerations.

Limitations And Caveats

The study was terminated after approximately 3 years due to future clinical development plans, including ethical considerations.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID